Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

Arianna Calcinotto, Maurilio Ponzoni, Roberto Ria, Matteo Grioni, Elena Cattaneo, Isabella Villa, Maria Teresa Sabrina Bertilaccio, Marta Chesi, Alessandro Rubinacci, Giovanni Tonon, Peter Leif Bergsagel, Angelo Vacca, Matteo Bellone

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

While multiple myeloma (MM) is almost invariably preceded by asymptomatic monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering MM (SMM), the alterations of the bone marrow (BM) microenvironment that establish progression to symptomatic disease are circumstantial. Here we show that in Vk*MYC mice harboring oncogene-driven plasma cell proliferative disorder, disease appearance associated with substantial modifications of the BM microenvironment, including a progressive accumulation of both CD8+ and CD4+ T cells with a dominant T helper type 1 (Th1) response. Progression from asymptomatic to symptomatic MM was characterized by further BM accrual of T cells with reduced Th1 and persistently increased Th2 cytokine production, which associated with accumulation of CD206+Tie2+ macrophages, and increased pro-angiogenic cytokines and microvessel density (MVD). Notably, MVD was also increased at diagnosis in the BM of MGUS and SMM patients that subsequently progressed to MM when compared with MGUS and SMM that remained quiescent. These findings suggest a multistep pathogenic process in MM, in which the immune system may contribute to angiogenesis and disease progression. They also suggest initiating a large multicenter study to investigate MVD in asymptomatic patients as prognostic factor for the progression and outcome of this disease.

Original languageEnglish (US)
JournalOncoImmunology
Volume4
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Multiple Myeloma
Disease Progression
Monoclonal Gammopathy of Undetermined Significance
Bone Marrow
Microvessels
Cytokines
T-Lymphocytes
Plasma Cells
Oncogenes
Multicenter Studies
Immune System
Macrophages

Keywords

  • Angiogenesis
  • Macrophages
  • Multiple myeloma
  • Smoldering multiple myeloma
  • T cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. / Calcinotto, Arianna; Ponzoni, Maurilio; Ria, Roberto; Grioni, Matteo; Cattaneo, Elena; Villa, Isabella; Bertilaccio, Maria Teresa Sabrina; Chesi, Marta; Rubinacci, Alessandro; Tonon, Giovanni; Bergsagel, Peter Leif; Vacca, Angelo; Bellone, Matteo.

In: OncoImmunology, Vol. 4, No. 6, 01.01.2015.

Research output: Contribution to journalArticle

Calcinotto, Arianna ; Ponzoni, Maurilio ; Ria, Roberto ; Grioni, Matteo ; Cattaneo, Elena ; Villa, Isabella ; Bertilaccio, Maria Teresa Sabrina ; Chesi, Marta ; Rubinacci, Alessandro ; Tonon, Giovanni ; Bergsagel, Peter Leif ; Vacca, Angelo ; Bellone, Matteo. / Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. In: OncoImmunology. 2015 ; Vol. 4, No. 6.
@article{a474d82ed7354ba38e18364bf763b6d3,
title = "Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma",
abstract = "While multiple myeloma (MM) is almost invariably preceded by asymptomatic monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering MM (SMM), the alterations of the bone marrow (BM) microenvironment that establish progression to symptomatic disease are circumstantial. Here we show that in Vk*MYC mice harboring oncogene-driven plasma cell proliferative disorder, disease appearance associated with substantial modifications of the BM microenvironment, including a progressive accumulation of both CD8+ and CD4+ T cells with a dominant T helper type 1 (Th1) response. Progression from asymptomatic to symptomatic MM was characterized by further BM accrual of T cells with reduced Th1 and persistently increased Th2 cytokine production, which associated with accumulation of CD206+Tie2+ macrophages, and increased pro-angiogenic cytokines and microvessel density (MVD). Notably, MVD was also increased at diagnosis in the BM of MGUS and SMM patients that subsequently progressed to MM when compared with MGUS and SMM that remained quiescent. These findings suggest a multistep pathogenic process in MM, in which the immune system may contribute to angiogenesis and disease progression. They also suggest initiating a large multicenter study to investigate MVD in asymptomatic patients as prognostic factor for the progression and outcome of this disease.",
keywords = "Angiogenesis, Macrophages, Multiple myeloma, Smoldering multiple myeloma, T cells",
author = "Arianna Calcinotto and Maurilio Ponzoni and Roberto Ria and Matteo Grioni and Elena Cattaneo and Isabella Villa and Bertilaccio, {Maria Teresa Sabrina} and Marta Chesi and Alessandro Rubinacci and Giovanni Tonon and Bergsagel, {Peter Leif} and Angelo Vacca and Matteo Bellone",
year = "2015",
month = "1",
day = "1",
doi = "10.1080/2162402X.2015.1008850",
language = "English (US)",
volume = "4",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "6",

}

TY - JOUR

T1 - Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

AU - Calcinotto, Arianna

AU - Ponzoni, Maurilio

AU - Ria, Roberto

AU - Grioni, Matteo

AU - Cattaneo, Elena

AU - Villa, Isabella

AU - Bertilaccio, Maria Teresa Sabrina

AU - Chesi, Marta

AU - Rubinacci, Alessandro

AU - Tonon, Giovanni

AU - Bergsagel, Peter Leif

AU - Vacca, Angelo

AU - Bellone, Matteo

PY - 2015/1/1

Y1 - 2015/1/1

N2 - While multiple myeloma (MM) is almost invariably preceded by asymptomatic monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering MM (SMM), the alterations of the bone marrow (BM) microenvironment that establish progression to symptomatic disease are circumstantial. Here we show that in Vk*MYC mice harboring oncogene-driven plasma cell proliferative disorder, disease appearance associated with substantial modifications of the BM microenvironment, including a progressive accumulation of both CD8+ and CD4+ T cells with a dominant T helper type 1 (Th1) response. Progression from asymptomatic to symptomatic MM was characterized by further BM accrual of T cells with reduced Th1 and persistently increased Th2 cytokine production, which associated with accumulation of CD206+Tie2+ macrophages, and increased pro-angiogenic cytokines and microvessel density (MVD). Notably, MVD was also increased at diagnosis in the BM of MGUS and SMM patients that subsequently progressed to MM when compared with MGUS and SMM that remained quiescent. These findings suggest a multistep pathogenic process in MM, in which the immune system may contribute to angiogenesis and disease progression. They also suggest initiating a large multicenter study to investigate MVD in asymptomatic patients as prognostic factor for the progression and outcome of this disease.

AB - While multiple myeloma (MM) is almost invariably preceded by asymptomatic monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering MM (SMM), the alterations of the bone marrow (BM) microenvironment that establish progression to symptomatic disease are circumstantial. Here we show that in Vk*MYC mice harboring oncogene-driven plasma cell proliferative disorder, disease appearance associated with substantial modifications of the BM microenvironment, including a progressive accumulation of both CD8+ and CD4+ T cells with a dominant T helper type 1 (Th1) response. Progression from asymptomatic to symptomatic MM was characterized by further BM accrual of T cells with reduced Th1 and persistently increased Th2 cytokine production, which associated with accumulation of CD206+Tie2+ macrophages, and increased pro-angiogenic cytokines and microvessel density (MVD). Notably, MVD was also increased at diagnosis in the BM of MGUS and SMM patients that subsequently progressed to MM when compared with MGUS and SMM that remained quiescent. These findings suggest a multistep pathogenic process in MM, in which the immune system may contribute to angiogenesis and disease progression. They also suggest initiating a large multicenter study to investigate MVD in asymptomatic patients as prognostic factor for the progression and outcome of this disease.

KW - Angiogenesis

KW - Macrophages

KW - Multiple myeloma

KW - Smoldering multiple myeloma

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84944474717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944474717&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1008850

DO - 10.1080/2162402X.2015.1008850

M3 - Article

AN - SCOPUS:84944474717

VL - 4

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 6

ER -